This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: RH Laboratories
In recognition of National Breast Cancer Awareness Month, RH Laboratories, manufacturer of Pandora for Women, has pledged to donate a percentage of October sales to the Susan G. Komen Foundation.
Atlanta, GA (PRWEB) October 09, 2012
RH Laboratories, the manufacturer of Pandora for Women, has announced plans to donate 10% of October sales to Susan G. Komen for the Cure in recognition of National Breast Cancer Awareness Month.
One in eight American women are diagnosed with breast cancer during their lifetime. Susan G. Komen for the Cure has contributed to many great victories in the fight against breast cancer, including more early detection, more effective treatments, a better understanding of the disease, and more hope than ever for a healthy life after breast cancer.
“Breast cancer is a devastating disease that affects nearly every American at some point in his/her lifetime,” says Joshua Maurice, President of RH Laboratories. “As a sexual wellness company, we strive to enhance women’s lives and empower them to be their happiest, healthiest selves.”
Pandora, which is available online and in select retailers, is the top-selling female sexual enhancement product in the country. The donation will be based off online sales of the three and eight-count cartons.
About RH Laboratories
RH Laboratories manufactures RockHard Weekend, an all-natural male sexual performance enhancer as well as Pandora, an all-natural sexual enhancer for women. RH Laboratories is constantly using innovative techniques to promote their products not only as supplements but also as a lifestyle. In addition to the products RH Labs manufactures, they distribute Forgiven, the world’s first alcohol metabolizer, Dr. Berman’s Intimate Accessories, and Victory Electronic Cigarettes.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebRHLabs_donates/BreastCancerAwareness/prweb9987502.htm
